Recent advances of CCR5 antagonists
1Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan. baba@m.kufm.kagoshima-u.ac.jp
Current Opinion in HIV and AIDS
|April 18, 2009
Summary
CCR5 antagonists are a promising new class of antiretroviral drugs. These small molecules effectively inhibit HIV-1 replication and show good tolerability and efficacy in clinical trials.
Area of Science:
- Virology
- Pharmacology
- Immunology
Background:
- The CCR5 receptor is crucial for HIV-1 entry into host cells.
- CCR5 antagonists represent a novel therapeutic strategy against HIV-1 infection.
Purpose of the Study:
- To review recent advances in CCR5 antagonists for HIV-1 treatment.
- To evaluate their antiviral activity, safety, and pharmacokinetics.
Main Methods:
- Review of scientific literature on CCR5 antagonists.
- Analysis of in vitro and in vivo data on antiviral efficacy.
- Examination of clinical trial results for safety and pharmacokinetic profiles.
Main Results:
- Several small-molecule CCR5 antagonists (e.g., maraviroc, vicriviroc) are potent inhibitors of R5 HIV-1 replication.
- These compounds are orally bioavailable and demonstrate significant viral load reduction in patients.
- Clinical studies indicate good tolerability and efficacy in HIV-1-infected individuals.
Conclusions:
- CCR5 antagonists are an effective new class of antiretroviral agents.
- They show broad activity against R5 HIV-1 strains.
- Clinical data support their use as well-tolerated and efficacious treatments for HIV-1 infection.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...